MindWalk Holdings Corp. (HYFT)Healthcare | Biotechnology | Austin, United States | NasdaqCM
1.41 USD
-0.02
(-1.399%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.39 -0.02 (-0.020%) ⇩ (July 13, 2026, 5:27 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:54 a.m. EDT
MindWalk Holdings presents a classic high-risk biotech dilemma where a brilliant long-term thesis clashes with immediate execution hurdles. The company is undeniably innovative, securing patents for AI-driven biological data layers and launching tools like ReefIQ, which aligns with the massive trend of AI in drug discovery. However, the financial reality is stark: the company is burning cash aggressively, with operating cash flow of -$11.2 million and negative free cash flow, while posting a massive loss on the latest quarter. This burn rate is the primary constraint; without significant capital raising or a near-term catalyst to turn the bleeding, the balance sheet will eventually force a deleveraging that hurts shareholders. The market reaction has been mixed but ultimately bearish on the trajectory. Despite a massive cumulative gain of +14,700% over the last nine years, the stock has suffered a brutal -68% decline in the most recent fiscal year, dragging the trailing twelve-month performance into negative territory. While the latest year shows a rebound (+54%), the recent price action confirms the struggle, trading below both its 50-day and 200-day moving averages, suggesting the broader market remains skeptical of the path to profitability. The analyst consensus is overwhelmingly bullish, with a mean target of $4.33 versus the current price of $1.43, but these targets rely entirely on the assumption that the company can secure funding and execute its pipeline without collapsing under the weight of its losses. For investors, this is a binary bet. You are either buying a potential 10x story in AI drug discovery or funding a company that may run out of cash before the technology matures. There is no middle ground here; the fundamentals are too weak to support a 'hold' strategy, and the momentum is currently insufficient to justify a 'buy' without heavy risk tolerance. The lack of dividends offers no cushion, leaving the entire investment thesis dependent on future equity issuance or operational miracles. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.196581 |
| AutoTheta | 0.197927 |
| AutoETS | 0.209748 |
| AutoARIMA | 0.246252 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 2.44 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.488 |
| Excess Kurtosis | -0.54 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 23.715 |
| Revenue per Share | 0.61 |
| Market Cap | 65,863,728 |
| Beta | 0.84 |
| Profit Margins | -43.60% |
| Previous Name | ImmunoPrecise Antibodies Ltd. |
| Website | https://www.mindwalkai.com |
As of July 11, 2026, 3:54 a.m. EDT: Speculator positioning is extremely thin and skewed toward out-of-the-money calls, indicating a speculative hope for a rapid spike rather than a structured hedge. The dominance of OTM call Open Interest suggests traders are betting on a breakout above current levels, while the lack of significant put volume implies a lack of organized downside protection. Implied volatility is notably higher for near-term puts than calls, hinting at asymmetric fear of a quick drop despite the bullish call bias.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2777778 |
| Address1 | Industrious 823 Congress Ave |
| Address2 | Suite 300 |
| All Time High | 42.75 |
| All Time Low | 0.005 |
| Ask | 1.77 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 272,910 |
| Average Daily Volume3 Month | 350,280 |
| Average Volume | 350,280 |
| Average Volume10Days | 272,910 |
| Beta | 0.835 |
| Bid | 1.35 |
| Bid Size | 2 |
| Book Value | 0.22446539 |
| City | Austin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.41 |
| Current Ratio | 3.741 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.445 |
| Day Low | 1.365 |
| Debt To Equity | 23.715 |
| Display Name | MindWalk |
| Dividend Date | 1,606,089,600 |
| Earnings Call Timestamp End | 1,784,754,000 |
| Earnings Call Timestamp Start | 1,784,754,000 |
| Earnings Timestamp | 1,784,750,400 |
| Earnings Timestamp End | 1,784,750,400 |
| Earnings Timestamp Start | 1,784,750,400 |
| Ebitda | -10,485,000 |
| Ebitda Margins | -0.37334 |
| Enterprise To Ebitda | -5.673 |
| Enterprise To Revenue | 2.118 |
| Enterprise Value | 59,481,584 |
| Eps Trailing Twelve Months | -0.1 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.502 |
| Fifty Day Average Change | -0.09200001 |
| Fifty Day Average Change Percent | -0.06125167 |
| Fifty Two Week Change Percent | -27.777779 |
| Fifty Two Week High | 3.246 |
| Fifty Two Week High Change | -1.8360001 |
| Fifty Two Week High Change Percent | -0.56561923 |
| Fifty Two Week Low | 0.99 |
| Fifty Two Week Low Change | 0.41999996 |
| Fifty Two Week Low Change Percent | 0.42424238 |
| Fifty Two Week Range | 0.99 - 3.246 |
| Financial Currency | CAD |
| First Trade Date Milliseconds | 1,010,413,800,000 |
| Float Shares | 45,371,224 |
| Free Cashflow | -3,994,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 81 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.57193 |
| Gross Profits | 16,062,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09021 |
| Held Percent Institutions | 0.0999 |
| Implied Shares Outstanding | 46,711,866 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,745,971,200 |
| Last Split Date | 1,606,089,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas. |
| Long Name | MindWalk Holdings Corp. |
| Market | us_market |
| Market Cap | 65,863,728 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_406475483 |
| Most Recent Quarter | 1,769,817,600 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -11,760,000 |
| Next Fiscal Year End | 1,777,507,200 |
| Non Diluted Market Cap | 66,797,968 |
| Number Of Analyst Opinions | 3 |
| Open | 1.4 |
| Operating Cashflow | -11,195,000 |
| Operating Margins | -0.8836 |
| Payout Ratio | 0.0 |
| Phone | 800 620 4187 |
| Post Market Change | -0.01999998 |
| Post Market Change Percent | -1.4184384 |
| Post Market Price | 1.39 |
| Post Market Time | 1,783,978,074 |
| Prev Name | ImmunoPrecise Antibodies Ltd. |
| Previous Close | 1.43 |
| Price Hint | 4 |
| Price To Book | 6.281592 |
| Price To Sales Trailing12 Months | 2.3452404 |
| Profit Margins | -0.43601 |
| Quick Ratio | 3.396 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.02 |
| Regular Market Change Percent | -1.3986 |
| Regular Market Day High | 1.445 |
| Regular Market Day Low | 1.365 |
| Regular Market Day Range | 1.365 - 1.445 |
| Regular Market Open | 1.4 |
| Regular Market Previous Close | 1.43 |
| Regular Market Price | 1.41 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 154,818 |
| Return On Assets | -0.18938999 |
| Return On Equity | -0.58824 |
| Revenue Growth | 0.524 |
| Revenue Per Share | 0.61 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 46,711,866 |
| Shares Percent Shares Out | 0.0183 |
| Shares Short | 853,725 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 877,348 |
| Short Name | MindWalk Holdings Corp. |
| Short Percent Of Float | 0.0185 |
| Short Ratio | 2.23 |
| Source Interval | 15 |
| State | TX |
| Symbol | HYFT |
| Target High Price | 5.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 4.33333 |
| Target Median Price | 5.0 |
| Total Cash | 14,072,000 |
| Total Cash Per Share | 0.283 |
| Total Debt | 3,524,000 |
| Total Revenue | 28,084,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.1 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.591225 |
| Two Hundred Day Average Change | -0.18122506 |
| Two Hundred Day Average Change Percent | -0.113890275 |
| Type Disp | Equity |
| Volume | 154,818 |
| Website | https://www.mindwalkai.com |
| Zip | 78,701 |